To know how LY2189265 affects (that is, increases, decreases or no change) blood pressure and heart rate in patients with type 2 diabetes mellitus

• Conditions: Type 2 Diabetes Mellitus; MedDRA version: 14.1Level: PTClassification code 10012601Term: Diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disorders; Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]

• Registration Number: EUCTR2010-019581-82-DK
• Lead Sponsor: Eli Lilly & Company

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-08-31
• Last Update Posted: 15 July 2013

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 693

Inclusion Criteria

Men and nonpregnant women aged =18 years with type 2 diabetes, treated with 1 or more oral antidiabetic medicines, an HbA1c =7.0% and =9.5%, a BP >90/60 mmHg and <140/90 mmHg; if hypertensive on 3 or less antihypertensive medications (same regimen for at least 1 month), and a stable weight with a BMI =23 kg/m2, will be enrolled.

See protocol for full details of inclusion criteria.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 25
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

See protocol for full details of exclusion criteria.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified